Source: Eur Respir J, 56 (5) 2001394; 10.1183/13993003.01394-2020
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Nakwon Kwak, Nicholas Winters, Jonathon R. Campbell, Edward D. Chan, Medea Gegia, Christoph Lange, Myungsun Lee, Vladimir Milanov, Dick Menzies, Jae-Joon Yim. Changes in treatment for multidrug-resistant tuberculosis according to national income. Eur Respir J, 56 (5) 2001394; 10.1183/13993003.01394-2020

Member's Comments

No comment yet.

Related content which might interest you: Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden country Source: Eur Respir J, 57 (6) 2002544; 10.1183/13993003.02544-2020 Year: 2021 Is multidrug-resistant tuberculosis on the rise in Mozambique? Results of a national drug resistance survey Source: Eur Respir J 2011; 37: 222-224 Year: 2011 Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia) Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Outbreak among household contacts of patients with multidrug-resistant tuberculosis Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 Extensively drug resistant tuberculosis (XDR TB) in a high income country: a report of four unrelated cases Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007 National advisory services for multidrug-resistant tuberculosis (MDRTB) in Europe: an ERS-TBnet survey Source: International Congress 2019 – Tuberculosis: treatment and management Year: 2019 Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country Source: Eur Respir J 2013; 42: 1291-1301 Year: 2013 Cameroon's multidrug-resistant tuberculosis treatment programme jeopardised by cross-border migration Source: Eur Respir J 2016; 47: 686-688 Year: 2016 Predictors of treatment outcome in multidrug-resistant tuberculosis in Portugal Source: Eur Respir J 2013; 42: 1747-1749 Year: 2013 Determinants of multidrug-resistant tuberculosis (MDR-TB) in Belarus Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview Year: 2012 Evaluation of treatment outcomes for multidrug-resistant tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 312s Year: 2001 Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008 Management of multidrug-resistant tuberculosis and patients in retreatment Source: Eur Respir J 2005; 25: 928-936 Year: 2005 Mycobacterium tuberculosis resistance profiles in index and secondary TB cases from the same household Source: International Congress 2018 – Challenges in tuberculosis care Year: 2018 Primary drug resistance against mycobacterium tuberculosis in a high burden country Source: Eur Respir J 2006; 28: Suppl. 50, 587s Year: 2006 Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries Source: Eur Respir J 2015; 46: 1563-1576 Year: 2015 Management of latent Mycobacterium tuberculosis infection: WHO guidelines for countries with a low tuberculosis burden Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces Year: 2016 Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk Source: Eur Respir J 2012; 39: 1425-1431 Year: 2012 Trends of multidrug-resistant tuberculosis clustering in Portugal Source: ERJ Open Res, 5 (1) 00151-2018; 10.1183/23120541.00151-2018 Year: 2019 Multidrug resistance of M. tuberculosis and its infuence on treatment efficiency of new detected patients with pulmonary tuberculosis in penitentiary institutions of Belarus Source: Eur Respir J 2007; 30: Suppl. 51, 272s Year: 2007